Evaluation of the analytical and clinical performance of the Micropoint qLabs INR point-of-care system

Thromb Res. 2019 Apr:176:104-107. doi: 10.1016/j.thromres.2019.02.012. Epub 2019 Feb 12.

Authors

J K van den Heuvel¹, N Kena², T van Hattum², D van Dolder³, M van Wijnen²

Affiliations

¹ Clinical Chemistry Laboratory, Meander Medical Centre, Amersfoort, the Netherlands. Electronic address: [email protected].
² Clinical Chemistry Laboratory, Meander Medical Centre, Amersfoort, the Netherlands.
³ Thrombosis unit Het Gooi, Hilversum, the Netherlands.

PMID: 30802691
DOI: 10.1016/j.thromres.2019.02.012

No abstract available

Keywords: International normalized ratio (INR); Point-of-care testing; Vitamin K antagonist (VKA); qLabs.

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use*
Blood Coagulation / drug effects
Drug Monitoring*
Humans
International Normalized Ratio*
Point-of-Care Systems*
Vitamin K / antagonists & inhibitors

Substances

Anticoagulants
Vitamin K